PathAIDigital Pathology company
PathAI is dedicated to improving patient outcomes with AI-powered pathology and meaningful collaboration with biopharma, laboratories and clinicians. Their platform promises substantial improvements to the accuracy of diagnosis and provides end-to-end data-driven pathology analysis.
- Category
- Digital Pathology
- Stage
- Series C
- Employees
- 400
- HQ
- Boston, United States
- Founded
- 2016
- Funding
- $355M